Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs,…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power…
Search Posts
Op-Eds
Demonize – Then Pulverize
Ten years ago last May, a new type of lawsuit was filed against the tobacco industry. That industry was no stranger to lawsuits; since the…
Op-Eds
The Toxic Politics of Biotech
How far does grass pollen travel? Ask someone who has hay fever, and the response is likely to be “much too far.” But…
Op-Eds
More Crop for the Drop
Your morning espresso at Starbucks will soon be more expensive. Unless, that is, they find a way to make it without water or coffee, both…
Op-Eds
Mr. Rifkin’s Pipe Dream
Professional worrier Jeremy Rifkin's pronouncements always remind me of the characterization by one-time Speaker of the House of Representatives Thomas B. Reed of…
Op-Eds
Taking the Scare Out of Biotech Crops
In the late 1990s, political scientist Gregory Conko had been studying food and pharmaceutical regulation as a fellow of the Competitive Enterprise Institute,…
News Release
“Frankenfood Myth” Debunks Biotech Scare
Contact for Interviews: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Jody Clarke, 202.331.2252 <?xml:namespace prefix = st1…